FI865025A0 - 2-(3,5-dihalogen-4-aminobensyl) imidazoliner. - Google Patents

2-(3,5-dihalogen-4-aminobensyl) imidazoliner.

Info

Publication number
FI865025A0
FI865025A0 FI865025A FI865025A FI865025A0 FI 865025 A0 FI865025 A0 FI 865025A0 FI 865025 A FI865025 A FI 865025A FI 865025 A FI865025 A FI 865025A FI 865025 A0 FI865025 A0 FI 865025A0
Authority
FI
Finland
Prior art keywords
imidazoliner
aminobensyl
dihalogen
Prior art date
Application number
FI865025A
Other languages
English (en)
Other versions
FI865025A (fi
Inventor
Martin Winn
John Francis Debernardis
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of FI865025A0 publication Critical patent/FI865025A0/fi
Publication of FI865025A publication Critical patent/FI865025A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
FI865025A 1985-12-11 1986-12-10 2-(3,5-dihalogen-4-aminobensyl) imidazoliner. FI865025A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/807,921 US4665095A (en) 1985-12-11 1985-12-11 Use of 2-[(3,5-dihalo-4-aminobenzyl)]imidazolines to stimulate alpha-1 adrenergic receptors and to treat nasal congestion

Publications (2)

Publication Number Publication Date
FI865025A0 true FI865025A0 (fi) 1986-12-10
FI865025A FI865025A (fi) 1987-06-12

Family

ID=25197433

Family Applications (1)

Application Number Title Priority Date Filing Date
FI865025A FI865025A (fi) 1985-12-11 1986-12-10 2-(3,5-dihalogen-4-aminobensyl) imidazoliner.

Country Status (9)

Country Link
US (1) US4665095A (fi)
EP (1) EP0230532B1 (fi)
JP (1) JPH07116038B2 (fi)
AU (1) AU591740B2 (fi)
CA (1) CA1282334C (fi)
DE (1) DE3674569D1 (fi)
FI (1) FI865025A (fi)
NO (1) NO864993L (fi)
NZ (1) NZ218334A (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970240A (en) * 1989-10-18 1990-11-13 Schering Corporation Fruity flavored nasal decongestant composition
US5114979A (en) * 1989-10-18 1992-05-19 Schering Corporation Fruity flavored nasal decongestant composition
JP4096363B2 (ja) * 1997-03-14 2008-06-04 日本新薬株式会社 鼻又は眼の充血治療剤
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
EP1075486A1 (en) * 1998-05-06 2001-02-14 Duke University Method of treating bladder and lower urinary tract syndromes
BRPI0707315A2 (pt) * 2006-01-27 2011-05-03 Hoffmann La Roche uso de 2-imidazol substituìdo de derivados de imidazolina
ES2381589T3 (es) * 2006-10-19 2012-05-29 F. Hoffmann-La Roche Ag Aminometil-4-imidazoles
EP2076496B1 (en) * 2006-10-19 2010-03-31 F. Hoffmann-Roche AG Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors
WO2008052907A1 (en) * 2006-11-02 2008-05-08 F. Hoffmann-La Roche Ag Substituted 2-imidazoles as modulators of the trace amine associated receptors
RU2456281C2 (ru) * 2006-11-16 2012-07-20 Ф. Хоффманн-Ля Рош Аг Замещенные 4-имидазолы, способ их получения и их применение
AU2007332641A1 (en) * 2006-12-13 2008-06-19 F. Hoffmann-La Roche Ag Novel 2 -imidazoles as ligands for trace amine associated receptors (TAAR)
US20080146523A1 (en) * 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
RU2473545C2 (ru) * 2007-02-02 2013-01-27 Ф.Хоффманн-Ля Рош Аг Новые 2-аминооксазолины в качестве лигандов taar1 для заболеваний цнс
RU2460725C2 (ru) * 2007-02-15 2012-09-10 Ф. Хоффманн-Ля Рош Аг Новые 2-аминооксазолины в качестве лигандов taar1
MX2009013742A (es) 2007-07-02 2010-01-26 Hoffmann La Roche 2-imidazolinas.
AU2008270444A1 (en) * 2007-07-03 2009-01-08 F. Hoffmann-La Roche Ag 4-imidazolines and their use as antidepressants
RU2010104632A (ru) * 2007-07-27 2011-09-20 Ф.Хоффманн-Ля Рош Аг (Ch) 2-азетидинметанамины и 2-пирролидинметанамины в качестве лигандов taar
BRPI0815038A2 (pt) * 2007-08-02 2015-03-17 Hoffmann La Roche Uso de derivados de benzamida para o tratamento de transtornos do cns
JP5341084B2 (ja) * 2007-08-03 2013-11-13 エフ．ホフマン−ラ ロシュ アーゲー Ｔａａｒ１リガンドとしてのピリジンカルボキシアミド及びベンズアミド誘導体
TW200922547A (en) * 2007-10-02 2009-06-01 Paer Johansson Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on α-adrenergic and/or β-adrenergic receptors of the sympathetic nervous system, related to improved clot strength
WO2010010014A1 (en) * 2008-07-24 2010-01-28 F. Hoffmann-La Roche Ag 4,5-dihydro-oxazol-2-yl derivatives
US8242153B2 (en) * 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US20100311798A1 (en) * 2009-06-05 2010-12-09 Decoret Guillaume 2-aminooxazolines as taar1 ligands
US8354441B2 (en) * 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
RU2731095C2 (ru) 2016-03-17 2020-08-28 Ф. Хоффманн-Ля Рош Аг Производное 5-этил-4-метил-пиразол-3-карбоксамида, обладающее активностью агониста taar
CA3066361A1 (en) 2017-06-07 2018-12-13 Shifamed Holdings, Llc Intravascular fluid movement devices, systems, and methods of use
CN111556763B (zh) 2017-11-13 2023-09-01 施菲姆德控股有限责任公司 血管内流体运动装置、系统
EP3746149A4 (en) 2018-02-01 2021-10-27 Shifamed Holdings, LLC INTRAVASCULAR BLOOD PUMPS AND METHODS OF USE AND METHODS OF MANUFACTURING
WO2021011473A1 (en) 2019-07-12 2021-01-21 Shifamed Holdings, Llc Intravascular blood pumps and methods of manufacture and use
WO2021016372A1 (en) 2019-07-22 2021-01-28 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
US11724089B2 (en) 2019-09-25 2023-08-15 Shifamed Holdings, Llc Intravascular blood pump systems and methods of use and control thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2731471A (en) * 1956-01-17 Nxg hi
US2868802A (en) * 1959-01-13 Nxchj
DE1617618B2 (de) * 1966-06-18 1976-05-20 Merck Patent Gmbh, 6100 Darmstadt Schleimhautabschwellende mittel zur lokalen applikation
DE1618005A1 (de) * 1966-09-22 1971-09-09 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen
US3660423A (en) * 1970-02-13 1972-05-02 Dow Chemical Co 2-(substituted benzyl)methyl-2-imidazolines
US3922282A (en) * 1975-01-17 1975-11-25 American Home Prod 2-Aryl-2-imidazoline-1-propionic acids and their esters
AU1623483A (en) * 1978-02-01 1983-10-13 Wellcome Foundation Limited, The Formulations of imidazole derivatives
US4506074A (en) * 1982-11-08 1985-03-19 Merck & Co., Inc. 2-[2-Pyridinyloxy(thio or amino)methyl]-1H-imidazoles and derivatives
US4461914A (en) * 1983-02-01 1984-07-24 American Cyanamid Company Method for the preparation of 1-(4'-amino-3',5'-dichlorophenyl)-2-alkyl(or dialkyl)aminoethanols
FR2549049B1 (fr) * 1983-07-13 1986-06-20 Chauvin Blache Lab Nouvelles amidines, leur procede de preparation et leur application therapeutique

Also Published As

Publication number Publication date
JPS62145067A (ja) 1987-06-29
NO864993D0 (no) 1986-12-10
NZ218334A (en) 1989-03-29
AU6631986A (en) 1987-06-18
JPH07116038B2 (ja) 1995-12-13
NO864993L (no) 1987-06-12
CA1282334C (en) 1991-04-02
EP0230532A1 (en) 1987-08-05
DE3674569D1 (de) 1990-10-31
AU591740B2 (en) 1989-12-14
FI865025A (fi) 1987-06-12
EP0230532B1 (en) 1990-09-26
US4665095A (en) 1987-05-12

Similar Documents

Publication Publication Date Title
FI865025A0 (fi) 2-(3,5-dihalogen-4-aminobensyl) imidazoliner.
FI861210A (fi) N,n'-dialkylguanidinodipeptider.
FI853193A0 (fi) Smaertstillande 1,2-benzisotiazol-3 -ylpiperazinderivat.
DE3783669D1 (de) Alpha-aryl-alpha-phenethyl-1h-1,2,4-triazol-1-propan-nitrile.
DE3669876D1 (de) 3,4-dihydrobenzopyranderivate.
FI875619A (fi) 6-benzoxazinyl- och 6-benzotiazonyl-2,3,4,5-tetrahydropyridazin-3-oner.
MX21592A (es) 1,3-oxazolidin-2-ona.
NL971040I1 (nl) 1-Dimethylcarbamoyl-3-gesubstitueerde-5-gesubstitueerde-1H-1,2,4-triazolen.
IT8521944A0 (it) 1,4-diidropiridine-2-sostituite.
DE3585315D1 (de) 5,6,7,8-tetrafluoranthrachinonderivate.
FI86060B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,4-naftalendioner.
DE3586745D1 (de) 9,11-epoxy-21-hydroxypregnan-derivate.
FI861950A0 (fi) 1,3-dioxan-etrar.
FI863300A (fi) 7-oxo-4-tia-1-azabicyclo/3,2,0/ hept-2-enderivat.
DE3684900D1 (de) 2,2'-bi-1h-imidazole.
FI855182A (fi) Foerfarande foer framstaellning av 1,3 -disubstituerade tetrahydropyridiner.
FI853421L (fi) 7-oxo-4-tia-1-azabicyklo/3,2,0/ hept-2-enderivat.
FI865158A0 (fi) 1-h-pyrido/3,2//1,4/-tiaziner.
FI863108A (fi) 3,7-disubstituerade 3-kefemfoereningar och foerfarande foer deras framstaellning.
IT8620495A0 (it) 2,4-dicloro-5-nitro-tiazolo.
DE3674284D1 (de) Kationische 1,2,3-thiadiazolazoverbindungen.
FI861194A0 (fi) Substituerade 1,8-naftyridinoner, foerfarande foer deras framstaellning och farmaceutiska blandningar innehaollande dessa.
DE3761091D1 (de) 2,6-dimethyl-p-benzochinontetraalkylketale.
ATE51400T1 (de) 3,4-dihydrobenzopyranderivate.
ATE58134T1 (de) 1,3-dioxanaether.

Legal Events

Date Code Title Description
FC Application refused
FC Application refused

Owner name: ABBOTT LABORATORIES